ERBB2 and breast carcinoma: As Pak1 and CaMKII are co-expressed and interact in human breast cancer cells, we tested the effect of small-molecule inhibitors of these kinases, alone and in combination, on the survival of Luminal, Her2 positive and TNBC cells.